Search

Your search keyword '"Nagae, Genta"' showing total 357 results

Search Constraints

Start Over You searched for: Author "Nagae, Genta" Remove constraint Author: "Nagae, Genta"
357 results on '"Nagae, Genta"'

Search Results

1. Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin

2. Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma

3. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation

4. Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival

5. Multiancestry genomic and transcriptomic analysis of gastric cancer

6. Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism

7. Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia

8. Aberrant proximal tubule DNA methylation underlies phenotypic changes related to kidney dysfunction in patients with diabetes.

9. Region‐specific DNA hydroxymethylation along the malignant progression of IDH‐mutant gliomas

11. Genetic and epigenetic basis of hepatoblastoma diversity

12. BRCC3 mutations in myeloid neoplasms

13. Integrated molecular profiling of juvenile myelomonocytic leukemia

15. Comprehensive epigenome characterization reveals diverse transcriptional regulation across human vascular endothelial cells

16. Supplementary Figures and Legends from Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma

17. Supplementary Tables from Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma

18. Data from Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma

19. Data from Three DNA Methylation Epigenotypes in Human Colorectal Cancer

21. Supplementary Data from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression

22. Supplementary Figures from Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability–High Colorectal Cancers

23. Supplementary Tables from Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability–High Colorectal Cancers

24. Supplementary Figure from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression

25. Supplementary Data from Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection

26. Supplementary Table from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression

27. Supplementary Methods, Tables 1-5, Figures 1-4 from Classification of Epstein–Barr Virus–Positive Gastric Cancers by Definition of DNA Methylation Epigenotypes

29. Publisher Correction: DNA demethylation is associated with malignant progression of lower-grade gliomas

30. DNA demethylation is associated with malignant progression of lower-grade gliomas

31. Loss of Viral Genome with Altered Immune Microenvironment During Tumour Progression of Epstein‐Barr Virus‐Associated Gastric Carcinoma

32. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

33. Combined burden and functional impact tests for cancer driver discovery using DriverPower

34. Integrative pathway enrichment analysis of multivariate omics data

35. Pathway and network analysis of more than 2500 whole cancer genomes

36. Divergent mutational processes distinguish hypoxic and normoxic tumours

37. Genomic footprints of activated telomere maintenance mechanisms in cancer

38. Distinct molecular profile of diffuse cerebellar gliomas

40. EPEN-27. Epigenetic dissection of spinal ependymomas (SP-EPN) separates tumors with and withoutNF2 mutation

41. Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism

42. Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia

44. EPCO-01. MOLECULAR PROFILING OF SPINAL CORD EPENDYMOMA

46. Molecular classification and diagnostics of upper urinary tract urothelial carcinoma

47. Molecular classification and diagnostics of upper urinary tract urothelial carcinoma

48. TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma

49. Cohesin mediates transcriptional insulation by CCCTC-binding factor

Catalog

Books, media, physical & digital resources